Marker Therapeutics Inc (MRKR)

[lasers]

$TPIV TPIV200 FRa vaccine solidly proven Mayo Phase1 clinical trial and now three Phase2 clinical trials with two underway and with the 3rd 280 person DOD soon.


As for Galena NeuVax, it is crystal clear now that Galena never did a Phase2 monotherapy NeuVax and went directly to a +700 person Phase3 monotherapy conducted at 144 clinical locations.

https://clinicaltrials.gov/ct2/show/NCT01479244?term=Galena+Neuvax&rank=1

Truly unbeleivable and very irresponsible of Galena mgmt resulting in $multi-millions lost for all costs incurred in the 144 locations, 700 persons P3 trial. IMO $20 to $30 mils lost and the $2 PPS drop is a $360 mil mkt cap lost for shareholders. Current Mkt cap = $63 mil.

Bottom line is that $TPIV vaccines under Dr. Wilson leadership is doing everything correctly and safely with one step at a time.

As for Galena, irresonsible mgmt actions, it will be years for shareholders to recover their losses, if ever!

$TPIV is a premium Long-Term hold IMO!